Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®

Biosimilars are biological products that are highly similar to existing products approved by health authorities. Demonstration of similarity starts with the comprehensive analysis of the reference product and its proposed biosimilar at the physicochemical and functional levels. Here, we report the r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:MAbs
Main Authors: Magnenat, Laurent, Palmese, Angelo, Fremaux, Christèle, D'Amici, Fabio, Terlizzese, Mariagrazia, Rossi, Mara, Chevalet, Laurent
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2016
Assuntos:
Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5240642/
https://ncbi.nlm.nih.gov/pubmed/27854156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1259046
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares